Tianjin Development Holdings Limited

Equities

882

HK0882007260

Multiline Utilities

Market Closed - Hong Kong S.E. 04:09:00 2024-07-15 am EDT 5-day change 1st Jan Change
1.84 HKD 0.00% Intraday chart for Tianjin Development Holdings Limited +1.10% +25.17%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lisheng Pharmaceutical Avails of 92-Day Structured Deposit Product MT
Tianjin Development’s Chairman Steps Down; Successor Named MT
Tianjin Development Holdings Limited Announces Board Changes CI
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4% MT
Tianjin Development Holdings Expects Up to 80% Jump in 2023 Profit MT
Tianjin Development Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3% MT
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan MT
Tianjin Lisheng Pharma Setting Up Venture Capital Fund MT
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake MT
Tianjin Development Holdings Limited Announces Board Changes CI
Tianjin Development Holdings Limited(SEHK:882) dropped from S&P Global BMI Index CI
Tianjin Development Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Lisheng Pharmaceutical's H1 Attributable Profit Jumps MT
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product MT
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal MT
Tianjin Development Holdings Limited Announces Executive Changes CI
Tianjin Lisheng Pharmaceutical's Q1 Attributable Profit Increases MT
Tianjin Development Logs 24% Drop in 2022 Profit MT
Tianjin Development Holdings Limited Announces Change of Directors and Change in Composition of Board Committees CI
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Lisheng Pharmaceutical's Audited 2022 Profit Marginally Higher Than Unaudited Results MT
Tianjin Development Holdings Warns of Up to 30% Decline in 2022 Profit MT
Tianjin Development Holdings Limited Provides Earnings Guidance for the the Year Ended 31 December 2022 CI
Chart Tianjin Development Holdings Limited
More charts
Tianjin Development Holdings Ltd is an investment holding company principally engaged in the supply of electricity, water, heat and thermal power. The Company operates its business through six segments. The Utilities segment engages in distribution of electricity, water, heat and thermal power. The Pharmaceutical segment engages in the manufacture and sale of pharmaceutical products and the provision of pharmaceutical research and development services as well as design, manufacture and printing for pharmaceutical packaging. The Hotel segment provides hotel operation services. The Electrical and Mechanical segment engages in the manufacture and sale of presses, mechanical and hydroelectric equipment as well as large scale pump units. The Port Services segment provides port services including container and cargo handling services. The Elevators and Escalators segment engages in the manufacture and sale of elevators and escalators.
More about the company
  1. Stock Market
  2. Equities
  3. 882 Stock
  4. News Tianjin Development Holdings Limited
  5. Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan